• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » German court issues 2nd injunction against Boston Scientific in OrbusNeich stent patent spat

German court issues 2nd injunction against Boston Scientific in OrbusNeich stent patent spat

May 14, 2013 By Brad Perriello

German court issues 2nd injunction against Boston Scientific in OrbusNeich stent patent spat

OrbusNeich Medical accused Boston Scientific (NYSE:BSX) of deliberately violating an injunction against importing drug-eluting stents into Germany and said a German court has issued its second import ban against Boston Scientific in their patent war.

Ft. Lauderdale- and Hong Kong-based OrbusNeich won the 1st injunction last month in the Dusseldorf Regional Court, after winning a patent decision in February. Earlier this month the company moved to enforce the injunction, and today accused its Natick, Mass.-based rival of scheming to get around the injunction.

In a press release, OrbusNeich accused Boston Scientific using a pair of British subsidiaries "to intentionally circumvent a prior order of the court banning sales of the same stent systems in Germany by other entities in the Boston Scientific corporate group."

"Rather than respecting the injunction, Boston Scientific immediately took steps to circumvent it. Boston Scientific transferred the German distribution of these products to Boston Scientific (UK) Ltd. and Boston Scientific Ltd. The company then sent a letter to its German customers advising them of the injunction and announcing that infringing products could be ordered from Boston Scientific UK," according to the release. "The letter provided contact information for orders and assured customers that a German-speaking salesperson would be at their disposal. These acts prompted the filing of the 2nd preliminary injunction request, which was granted yesterday and which Boston Scientific may appeal. OrbusNeich has immediately initiated enforcement of this new preliminary injunction."

"If Boston Scientific keeps shifting distribution to other entities, we will continue to seek further injunctions and any other penalties available under German law," added chairman & CEO Al Novak. "Further to this second preliminary injunction, we have also filed a request that the [Dusseldorf] Regional Court penalize Boston Scientific for the recent violations of the court’s order."

The injunction prevents Boston Scientific from selling in Germany its Promus Element, Promus Element Plus, Promus Premier, Omega, Taxus Element or Synergy stents in any of the small vessel, small workhorse or workhorse diameters and prevents Boston Scientific from encouraging other companies to sell the products in Germany.

The German court last month granted OrbusNeich a preliminary injunction in the legal row over coronary stent patents. The German win was part of the smattering of lawsuits OrbusNeich filed after winning a European patent decision in February.

"Boston Scientific strongly believes that our products do not infringe Orbus’ patents," spokesman Steve Campanini told MassDevice.com in an email late last month. "The company will appeal the decision and seek remedies for loss of revenue stemming from the injunction. In the meantime, we will abide by the German court’s rulings."

OrbusNeich is also seeking a permanent injunction, damages and a recall of any infringing products that have not been used in patients. A hearing is slated for early 2014, OrbusNeich said.

Although it’s more likely to end in a royalty settlement, according to Leerink Swann analyst Danielle Antalffy, the injunction could cost BSX about $90 million in sales and 2¢ in earnings per share.

It’s not the first legal dance for the 2 companies, which are also fighting in U.S. courts. A lawsuit filed here in 2009 has been stayed pending review of the patents in question. OrbusNeich is "reviewing its options with respect to this litigation," according to a company statement.

Filed Under: Legal News, News Well, Patent Infringement, Stents Tagged With: Boston Scientific, OrbusNeich, Stent Wars

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy